基孔肯雅热市场－全球产业规模、份额、趋势、机会和预测，按诊断、治疗、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球基孔肯雅热市值为4.9323亿美元，预计2030年将以7.28%的复合年增长率成长至7.5191亿美元。全球基孔肯雅热市场涵盖了针对这种蚊媒病毒感染的治疗干预措施、诊断解决方案和预防措施，这种病毒感染主要由埃及斑蚊和白纹伊蚊传播。

主要市场驱动因素

全球基孔肯雅热发生率的上升显着推动了对诊断工具、治疗手段和预防性疫苗的市场需求。疾病流行率的提高需要更广泛的检测和治疗，加速了产品研发。

主要市场挑战

监测能力和诊断准备的持续差距，严重阻碍了全球基孔肯雅热市场的成长。这项挑战直接影响了市场发展，延误了疾病的及时发现和有效管理，从而限制了对诊断解决方案和后续治疗介入的需求。

主要市场趋势

mRNA疫苗技术的进步代表着一个关键趋势，它透过实现快速抗原鑑定和灵活的生产工艺，加快了基孔肯雅疫苗的研发週期。这项技术能够更快地应对新出现的病毒株，并有望实现高效的疫苗效力。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球基孔肯雅热市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依诊断方法（基于酵素连结免疫吸附试验、血清学检测、病毒学检测）
  • 依治疗方法（西医、顺势疗法、阿育吠陀疗法、其他）
  • 按最终使用者（医院和诊所、门诊手术护理、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美基孔肯雅热市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲基孔肯雅热市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区基孔肯雅热市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲基孔肯雅热市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲基孔肯雅热市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球基孔肯雅热市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Quest Diagnostics, Inc.
• Abbott Laboratories, Inc.
• Genome Diagnostics Pvt. Ltd.
• Altona Diagnostics GmbH
• Bio-Rad Laboratories, Inc.
• Taj Pharmaceuticals Ltd.
• Etubics Corporation
• Shanghai Solve Care Co. Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Chikungunya Fever Market, valued at USD 493.23 Million in 2024, is projected to experience a CAGR of 7.28% to reach USD 751.91 Million by 2030. The Global Chikungunya Fever Market encompasses therapeutic interventions, diagnostic solutions, and preventive measures addressing this mosquito-borne viral infection, primarily transmitted by *Aedes aegypti* and *Aedes albopictus* mosquitoes.

Key Market Drivers

The rising global incidence of Chikungunya Fever significantly drives market demand for diagnostic tools, therapeutic interventions, and preventive vaccines. Heightened disease prevalence necessitates more widespread testing and treatment, accelerating product development. According to the European Centre for Disease Prevention and Control, as of November 2024, approximately 480,000 Chikungunya cases were reported worldwide, underscoring the expanding public health challenge.

Key Market Challenges

The persistent gap in surveillance capabilities and diagnostic readiness represents a significant impediment to the growth of the Global Chikungunya Fever Market. This challenge directly hampers the market by delaying timely detection and effective management of the disease, thereby limiting the demand for diagnostic solutions and subsequent therapeutic interventions. When infections go undetected or are misdiagnosed, the market for related products cannot expand to its full potential.

Key Market Trends

Advances in mRNA Vaccine Technology represent a pivotal trend, expediting the development cycle for Chikungunya vaccines by enabling rapid antigen identification and flexible manufacturing processes. This technology allows for quicker responses to emerging viral strains and offers the potential for high-efficacy profiles. According to *Vaccine*, in June 2023, Moderna's mRNA-1388 Chikungunya vaccine candidate demonstrated favorable safety and immunogenicity in a Phase 1 study, eliciting substantial and persistent neutralizing antibody responses in healthy adults.

Key Market Players

• Quest Diagnostics, Inc.
• Abbott Laboratories, Inc.
• Genome Diagnostics Pvt. Ltd.
• Altona Diagnostics GmbH
• Bio-Rad Laboratories, Inc.
• Taj Pharmaceuticals Ltd.
• Etubics Corporation
• Shanghai Solve Care Co. Ltd.

Report Scope:

In this report, the Global Chikungunya Fever Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chikungunya Fever Market, By Diagnosis:

• ELISA Based Assays
• Serological Tests
• Virological Tests

Chikungunya Fever Market, By Treatment:

• Allopathy
• Homeopathy
• Ayurveda
• Others

Chikungunya Fever Market, By End User:

• Hospital & Clinics
• Ambulatory Surgical care
• Others

Chikungunya Fever Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Chikungunya Fever Market.

Available Customizations:

Global Chikungunya Fever Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chikungunya Fever Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Diagnosis (ELISA Based Assays, Serological Tests, Virological Tests)
  • 5.2.2. By Treatment (Allopathy, Homeopathy, Ayurveda, Others)
  • 5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Chikungunya Fever Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Diagnosis
  • 6.2.2. By Treatment
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Chikungunya Fever Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Diagnosis
      • 6.3.1.2.2. By Treatment
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Chikungunya Fever Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Diagnosis
      • 6.3.2.2.2. By Treatment
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Chikungunya Fever Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Diagnosis
      • 6.3.3.2.2. By Treatment
      • 6.3.3.2.3. By End User

7. Europe Chikungunya Fever Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Diagnosis
  • 7.2.2. By Treatment
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Chikungunya Fever Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Diagnosis
      • 7.3.1.2.2. By Treatment
      • 7.3.1.2.3. By End User
  • 7.3.2. France Chikungunya Fever Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Diagnosis
      • 7.3.2.2.2. By Treatment
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Chikungunya Fever Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Diagnosis
      • 7.3.3.2.2. By Treatment
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Chikungunya Fever Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Diagnosis
      • 7.3.4.2.2. By Treatment
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Chikungunya Fever Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Diagnosis
      • 7.3.5.2.2. By Treatment
      • 7.3.5.2.3. By End User

8. Asia Pacific Chikungunya Fever Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Diagnosis
  • 8.2.2. By Treatment
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Chikungunya Fever Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Diagnosis
      • 8.3.1.2.2. By Treatment
      • 8.3.1.2.3. By End User
  • 8.3.2. India Chikungunya Fever Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Diagnosis
      • 8.3.2.2.2. By Treatment
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Chikungunya Fever Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Diagnosis
      • 8.3.3.2.2. By Treatment
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Chikungunya Fever Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Diagnosis
      • 8.3.4.2.2. By Treatment
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Chikungunya Fever Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Diagnosis
      • 8.3.5.2.2. By Treatment
      • 8.3.5.2.3. By End User

9. Middle East & Africa Chikungunya Fever Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Diagnosis
  • 9.2.2. By Treatment
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Chikungunya Fever Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Diagnosis
      • 9.3.1.2.2. By Treatment
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Chikungunya Fever Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Diagnosis
      • 9.3.2.2.2. By Treatment
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Chikungunya Fever Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Diagnosis
      • 9.3.3.2.2. By Treatment
      • 9.3.3.2.3. By End User

10. South America Chikungunya Fever Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Diagnosis
  • 10.2.2. By Treatment
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Chikungunya Fever Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Diagnosis
      • 10.3.1.2.2. By Treatment
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Chikungunya Fever Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Diagnosis
      • 10.3.2.2.2. By Treatment
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Chikungunya Fever Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Diagnosis
      • 10.3.3.2.2. By Treatment
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Chikungunya Fever Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Quest Diagnostics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott Laboratories, Inc.
• 15.3. Genome Diagnostics Pvt. Ltd.
• 15.4. Altona Diagnostics GmbH
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Taj Pharmaceuticals Ltd.
• 15.7. Etubics Corporation
• 15.8. Shanghai Solve Care Co. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer